Study protocol for development and validation of a single tool to assess risks of stroke, diabetes mellitus, myocardial infarction and dementia: DemNCD-Risk.
Scherazad KootarMd Hamidul HuqueKim M KielyCraig S AndersonLouisa R JormMiia KivipeltoNicola T LautenschlagerFiona E MatthewsJonathan Edward ShawRachel A WhitmerRuth PetersKaarin Jane AnsteyPublished in: BMJ open (2023)
Ethics approval is provided by the University of New South Wales Human Research Ethics Committee (UNSW HREC; protocol numbers HC200515, HC3413). All data are deidentified and securely stored on servers at Neuroscience Research Australia. Study findings will be presented at conferences and published in peer-reviewed journals. The tool will be accessible as a public health resource. Knowledge translation and implementation work will explore strategies to apply the tool in clinical practice.
Keyphrases
- public health
- clinical practice
- big data
- healthcare
- endothelial cells
- primary care
- randomized controlled trial
- heart failure
- atrial fibrillation
- global health
- mild cognitive impairment
- left ventricular
- electronic health record
- induced pluripotent stem cells
- metabolic syndrome
- adipose tissue
- quality improvement
- pluripotent stem cells
- brain injury
- deep learning
- subarachnoid hemorrhage
- weight loss